|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: tolcapone
Summary for Generic Name: tolcapone
| |||||||||||||||
Clinical Trials for: tolcaponePilot Study of Tolcapone in Smokers Status: Completed Condition: Nicotine Dependence Tolcapone Treatment of Pathological Gambling Status: Completed Condition: Pathological Gambling Effects of Tolcapone on Frontotemporal Dementia Status: Recruiting Condition: Frontotemporal Lobar Degeneration Neural Substrates in Nicotine Withdrawal Status: Completed Condition: Tobacco Use Disorder Clinical Trial of Tolcapone for Cognition in Schizophrenia Status: Recruiting Condition: Schizophrenia Assessment of Potential Interactions Between Cocaine and Tolcapone - 1 Status: Active, not recruiting Condition: Cocaine-Related Disorders A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors Status: Recruiting Condition: Impulsive Behavior Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors Status: Completed Condition: Parkinson Disease Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms Llc | TASMAR | tolcapone | TABLET; ORAL | 020697 | Jan 29, 1998 | DISCN | No | 5,476,875 | <disabled> | TREATMENT OF PARKINSON'S DISEASE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valeant Pharms Llc | TASMAR | tolcapone | TABLET; ORAL | 020697 | Jan 29, 1998 | RX | Yes | 5,476,875 | <disabled> | TREATMENT OF PARKINSON'S DISEASE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc